Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0062 Transporter Info | ||||
| Gene Name | ABCC9 | ||||
| Protein Name | Sulfonylurea receptor 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs704212 | ||||
| Site of GPD | chr12:21891410 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | C>T | ||||
| Minor Allele Frequency | T=0.2636/1320 (Global) | ||||
| Allele T | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Montelukast | Drug Info | Healthy Individuals | Correlated with the decreased drug concentration in healthy individuals (compare with allele C) | [ 1] | |
| References | |||||
| 1 | Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics. Clin Pharmacol Ther. 2018 Jul;104(1):158-168. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.